First glycopeptide-resistant Enterococcus faecium isolate from blood culture in Ankara, Turkey [3]

Emerging Infectious Diseases

Volumn 7, Issue 1, 2001, Pages 160-161

  Basustaoglu, Ahmet ^a   Aydogan, Hakan ^a   Beyan, Cengiz ^a   Yalcin, Atilla ^a   Unal, Serhat ^b  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFTAZIDIME; CIPROFLOXACIN; CYTARABINE; DAUNORUBICIN; IMIPENEM; LEVOFLOXACIN; POLYPEPTIDE ANTIBIOTIC AGENT; TEICOPLANIN; VANCOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATION; BLOOD CULTURE; CASE REPORT; CLINICAL EXAMINATION; ENTEROCOCCUS FAECIUM; FEBRILE NEUTROPENIA; HUMAN; LETTER; MALE; MINIMUM INHIBITORY CONCENTRATION; TURKEY (REPUBLIC);

EID: 0035104770     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0701.010128     Document Type: Letter

References (5)

1. Plasmidmediated resistance to vancomycin and teicoplanin in Enterococcus faecium
2. High level vancomycin-resistant enterococci causing hospital infection
3. Detection of glycopeptide resistance genotypes and identification of the species level of clinically relevant enterococci by PCR
4. Heterogeneity of the VanA gene clusters in clinical isolates of enterococci from the northeastern United States
5. Recommendations for preventing the spread of vancomycin resistance